Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03262818 · ClinicalTrials.gov registry record · Phase 1
Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT03262818 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 40 participants.
The verdict
NCT03262818, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The investigators have developed co-registered photoacoustic and ultrasound (US) imaging technique that allows the investigators to visualize tumor structure and functional changes simultaneously, which may potentially reveal early tumor angiogenesis development that is not available by US alone. The ability to detect early angiogenesis changes, as well as tumor morphology changes in the ovary, using a non-invasive imaging modality will greatly enhance the care for women.
Interventions
- DEVICE Transvaginal ultrasound
- DEVICE Ultrasound/Photoacoustic imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2018-11-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03262818
The ClinicalTrials.gov registry entry for NCT03262818 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transvaginal ultrasound is the first listed.
NCT03262818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03262818 about?
NCT03262818 is a clinical study titled "Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary". The investigators have developed co-registered photoacoustic and ultrasound (US) imaging technique that allows the investigators to visualize tumor structure and functional changes simultaneously, which may potentially reveal early tumor angiogenesis development that is not available by US alone. Th...
What is the current status of trial NCT03262818?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2017-02-01. Estimated completion is 2018-11-20.
What interventions are being tested in trial NCT03262818?
The interventions under investigation include: Transvaginal ultrasound (DEVICE), Ultrasound/Photoacoustic imaging (DEVICE).
Who is sponsoring clinical trial NCT03262818?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.